Mon. 13 May 2024, 8:19am ET
Benzinga
Earnings, Earnings Beats, News
Barinthus Biotherapeutics (NASDAQ:BRNS) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.54) by 25.93 percent. This is a 16.67 percent increase over losses of $(0.48) per share from the same period last year.